Nicolas Dupré

8.3k total citations · 1 hit paper
148 papers, 4.7k citations indexed

About

Nicolas Dupré is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Nicolas Dupré has authored 148 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Neurology, 57 papers in Cellular and Molecular Neuroscience and 46 papers in Molecular Biology. Recurrent topics in Nicolas Dupré's work include Amyotrophic Lateral Sclerosis Research (43 papers), Genetic Neurodegenerative Diseases (41 papers) and Parkinson's Disease Mechanisms and Treatments (36 papers). Nicolas Dupré is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (43 papers), Genetic Neurodegenerative Diseases (41 papers) and Parkinson's Disease Mechanisms and Treatments (36 papers). Nicolas Dupré collaborates with scholars based in Canada, United States and France. Nicolas Dupré's co-authors include Guy A. Rouleau, Patrick A. Dion, Jean‐Pierre Bouchard, Paul N. Valdmanis, Vincent Meininger, William Camu, François Salachas, Dan Spiegelman, Lucette Lacomblez and Edor Kabashi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Nicolas Dupré

146 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis

2008 1.2k citations Patrick A. Dion, Dan Spiegelman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicolas Dupré Canada	33	2.9k	2.0k	1.4k	991	837	148	4.7k
Andrea Malaspina United Kingdom	38	3.0k 1.0×	1.6k 0.8×	1.4k 1.0×	718 0.7×	740 0.9×	104	4.7k
Marianne de Visser Netherlands	42	2.5k 0.9×	1.8k 0.9×	1.6k 1.1×	707 0.7×	500 0.6×	86	4.4k
Richard W. Orrell United Kingdom	36	2.2k 0.8×	1.7k 0.8×	1.2k 0.8×	700 0.7×	609 0.7×	90	4.1k
Denise A. Figlewicz United States	33	2.7k 0.9×	2.5k 1.2×	1.7k 1.2×	1.3k 1.3×	927 1.1×	81	5.4k
Eisaku Ohama Japan	37	3.3k 1.1×	2.1k 1.0×	699 0.5×	1.4k 1.4×	955 1.1×	160	5.9k
John Ravits United States	40	5.3k 1.8×	2.8k 1.4×	3.1k 2.2×	1.2k 1.2×	1.4k 1.7×	93	7.5k
Hidefumi Ito Japan	38	1.7k 0.6×	1.5k 0.7×	564 0.4×	838 0.8×	1.0k 1.2×	145	3.9k
A. Prelle Italy	38	1.5k 0.5×	2.6k 1.3×	836 0.6×	709 0.7×	337 0.4×	112	4.7k
Alice Chen‐Plotkin United States	42	3.3k 1.1×	2.1k 1.1×	689 0.5×	848 0.9×	932 1.1×	117	6.1k
Kiyomitsu Oyanagi Japan	38	1.9k 0.7×	1.2k 0.6×	423 0.3×	1.1k 1.1×	812 1.0×	173	4.2k

Countries citing papers authored by Nicolas Dupré

Since Specialization

Citations

This map shows the geographic impact of Nicolas Dupré's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Dupré with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Dupré more than expected).

Fields of papers citing papers by Nicolas Dupré

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Dupré. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Dupré. The network helps show where Nicolas Dupré may publish in the future.

Co-authorship network of co-authors of Nicolas Dupré

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Dupré. A scholar is included among the top collaborators of Nicolas Dupré based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Dupré. Nicolas Dupré is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blais, Mathieu, et al.. (2025). ARSACS: Clinical Features, Pathophysiology and iPS-Derived Models. The Cerebellum. 24(1). 24–24. 3 indexed citations

Beaudin, Marie, Nicolas Dupré, & Mario Manto. (2024). The importance of synthetic pharmacotherapy for recessive cerebellar ataxias. Expert Review of Neurotherapeutics. 24(9). 897–912. 1 indexed citations

Béland, Louis‐Charles, et al.. (2024). Chronically activated microglia in ALS gradually lose their immune functions and develop unconventional proteome. Glia. 72(7). 1319–1339. 4 indexed citations

Senkevich, Konstantin, Eric Yu, Jamil Ahmad, et al.. (2024). Are rare heterozygous SYNJ1 variants associated with Parkinson’s disease?. npj Parkinson s Disease. 10(1). 201–201.

Ross, Jay P., Fulya Akçimen, Calwing Liao, et al.. (2023). Rare-variant and polygenic analyses of amyotrophic lateral sclerosis in the French-Canadian genome. Genetics in Medicine. 26(1). 100967–100967. 1 indexed citations

Picher‐Martel, Vincent, Pierre Cordeau, Hannah Kaneb, et al.. (2023). Distinct Plasma Immune Profile in ALS Implicates sTNFR-II in pAMPK/Leptin Homeostasis. International Journal of Molecular Sciences. 24(6). 5065–5065. 3 indexed citations

Ross, Jay P., Fulya Akçimen, Calwing Liao, et al.. (2022). Questioning the Association of the STMN2 Dinucleotide Repeat With Amyotrophic Lateral Sclerosis. Neurology Genetics. 8(4). e678–e678. 1 indexed citations

Estiar, Mehrdad A., Simon Veyron, Kheireddin Mufti, et al.. (2022). Genetic, structural and clinical analysis of spastic paraplegia 4. Parkinsonism & Related Disorders. 98. 62–69. 14 indexed citations

Mei, Jie, Mathieu Blais, Sara Carazo, et al.. (2021). Chemosensory Dysfunctions Induced by COVID-19 Can Persist up to 7 Months: A Study of Over 700 Healthcare Workers. Chemical Senses. 46. 28 indexed citations

10.

Yoon, Grace, Mehrdad A. Estiar, Simon Veyron, et al.. (2021). GCH1 mutations in hereditary spastic paraplegia. Clinical Genetics. 100(1). 51–58. 5 indexed citations

11.

Estiar, Mehrdad A., Eric Yu, Jay P. Ross, et al.. (2021). Evidence for Non‐Mendelian Inheritance in Spastic Paraplegia 7. Movement Disorders. 36(7). 1664–1675. 14 indexed citations

12.

Rudakou, Uladzislau, Eric Yu, Lynne Krohn, et al.. (2020). Targeted sequencing of Parkinson’s disease loci genes highlights SYT11, FGF20 and other associations. Brain. 144(2). 462–472. 29 indexed citations

13.

Beaudin, Marie, Leila Sellami, Andréane Lavallée, et al.. (2020). Characterization of the phenotype with cognitive impairment and protein mislocalization in SCA34. Neurology Genetics. 6(2). e403–e403. 23 indexed citations

14.

Yu, Eric, Uladzislau Rudakou, Lynne Krohn, et al.. (2020). Analysis of Heterozygous PRKN Variants and Copy‐Number Variations in Parkinson's Disease. Movement Disorders. 36(1). 178–187. 29 indexed citations

15.

Zhou, Sirui, Ziv Gan‐Or, Amirthagowri Ambalavanan, et al.. (2018). Genome-wide association analysis identifies new candidate risk loci for familial intracranial aneurysm in the French-Canadian population. Scientific Reports. 8(1). 4356–4356. 10 indexed citations

16.

He, Qin, Jennifer A. Ruskey, Sirui Zhou, et al.. (2018). TOX3 Variants Are Involved in Restless Legs Syndrome and Parkinson’s Disease with Opposite Effects. Journal of Molecular Neuroscience. 64(3). 341–345. 8 indexed citations

17.

Ruskey, Jennifer A., Sirui Zhou, Raoul Santiago, et al.. (2018). The GBA p.Trp378Gly mutation is a probable French‐Canadian founder mutation causing Gaucher disease and synucleinopathies. Clinical Genetics. 94(3-4). 339–345. 7 indexed citations

18.

Rudakou, Uladzislau, Bouchra Ouled Amar Bencheikh, Jennifer A. Ruskey, et al.. (2018). Common and rare GCH1 variants are associated with Parkinson's disease. Neurobiology of Aging. 73. 231.e1–231.e6. 17 indexed citations

19.

Ross, Jay P., Nicolas Dupré, Yves Dauvilliers, et al.. (2016). Analysis of DNAJC13 mutations in French-Canadian/French cohort of Parkinson's disease. Neurobiology of Aging. 45. 212.e13–212.e17. 28 indexed citations

20.

Leblond, Claire S., Ziv Gan‐Or, Dan Spiegelman, et al.. (2015). Replication study of MATR3 in familial and sporadic amyotrophic lateral sclerosis. Neurobiology of Aging. 37. 209.e17–209.e21. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact